Quantitative benefit-risk analysis for prophylactic vaccines in the context of FDAs benefit-risk framework.

Yang H, Yogurtcu ON, Nukala U, Funk PR, Izurieta HS, Forshee RA

Open source

DOI
10.1038/s41541-025-01342-3
Published
2026 Feb 5
Container
NPJ vaccines
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41541-025-01342-3,
  title = {Quantitative benefit-risk analysis for prophylactic vaccines in the context of FDAs benefit-risk framework.},
  author = {Yang H and Yogurtcu ON and Nukala U and Funk PR and Izurieta HS and Forshee RA},
  year = {2026},
  journal = {NPJ vaccines},
  doi = {10.1038/s41541-025-01342-3},
  url = {https://doi.org/10.1038/s41541-025-01342-3}
}

RIS

TY  - JOUR
TI  - Quantitative benefit-risk analysis for prophylactic vaccines in the context of FDAs benefit-risk framework.
AU  - Yang H
AU  - Yogurtcu ON
AU  - Nukala U
AU  - Funk PR
AU  - Izurieta HS
AU  - Forshee RA
PY  - 2026
JO  - NPJ vaccines
DO  - 10.1038/s41541-025-01342-3
UR  - https://doi.org/10.1038/s41541-025-01342-3
ER  - 

APA

H, Y., ON, Y., U, N., PR, F., HS, I., & RA, F. (2026). Quantitative benefit-risk analysis for prophylactic vaccines in the context of FDAs benefit-risk framework.. NPJ vaccines. https://doi.org/10.1038/s41541-025-01342-3

Source records